Nuvalent, Inc.
NASDAQ:NUVL
84.22 (USD) • At close December 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2.432 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2.432 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 60.551 | 49.166 | 38.634 | 35.585 | 29.611 | 25.922 | 22.125 | 22.855 | 14.625 | 13.558 | 12.693 | 13.194 | 9.055 | 7.826 | 5.484 | 4.699 | 3.721 | 3.657 | 3.326 |
| General & Administrative Expenses
| 15.78 | 15.984 | 13.954 | 10.852 | 9.172 | 8.14 | 8.085 | 6.444 | 5.763 | 5.175 | 4.995 | 4.184 | 3.372 | 2.024 | 0.678 | 0.515 | 0.319 | 0.349 | 0.319 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 15.78 | 15.984 | 13.954 | 10.852 | 9.172 | 8.14 | 8.085 | 6.444 | 5.763 | 5.175 | 4.995 | 4.184 | 3.372 | 2.024 | 0.678 | 0.515 | 0.319 | 0.349 | 0.319 |
| Other Expenses
| 0 | 0 | 0 | -5.018 | 0 | 0 | 5.018 | 3.176 | 0.672 | 0.267 | 0.139 | 0.089 | 0.001 | 0.012 | -0.623 | -1.366 | -0.738 | -4.551 | 9.004 |
| Operating Expenses
| 76.331 | 65.15 | 52.588 | 46.437 | 38.783 | 34.062 | 30.21 | 29.299 | 20.388 | 18.733 | 17.688 | 17.378 | 12.427 | 9.85 | 6.162 | 5.214 | 4.04 | 4.006 | 3.645 |
| Operating Income
| -76.331 | -65.15 | -52.588 | -46.437 | -38.783 | -34.062 | -30.21 | -29.299 | -20.388 | -18.733 | -17.688 | -17.378 | -12.427 | -9.85 | -6.162 | -5.214 | -4.04 | -4.006 | -3.645 |
| Operating Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7.146 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| -7.974 | 8.154 | 8.489 | 8.145 | 5.138 | 4.972 | 5.018 | 3.176 | 0.672 | 0.267 | 0.139 | 0.089 | 0.001 | 0.012 | -0.623 | -1.366 | -0.738 | -4.551 | 9.004 |
| Income Before Tax
| -84.305 | -56.996 | -44.099 | -38.292 | -33.645 | -29.09 | -25.192 | -26.123 | -19.716 | -18.466 | -17.549 | -17.289 | -12.426 | -9.838 | -6.785 | -6.58 | -4.778 | -8.557 | 5.359 |
| Income Before Tax Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7.109 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0.04 | 0.17 | -0.383 | 5.018 | 0.04 | -0.122 | -5.018 | -6.352 | -0.672 | -0.267 | -0.139 | 4.971 | -0.001 | -0.012 | 0.623 | 1.366 | 0.738 | 4.551 | -9.004 |
| Net Income
| -84.345 | -57.166 | -44.482 | -38.292 | -33.645 | -29.09 | -20.174 | -19.771 | -19.044 | -18.199 | -17.41 | -17.289 | -12.426 | -9.838 | -6.785 | -6.58 | -4.778 | -8.557 | 5.359 |
| Net Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7.109 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -1.28 | -0.88 | -0.69 | -0.62 | -0.59 | -0.51 | -0.36 | -0.37 | -0.39 | -0.38 | -0.36 | -0.36 | -0.39 | -0.21 | -0.3 | -0.29 | -0.21 | -0.37 | 0.23 |
| EPS Diluted
| -1.28 | -0.88 | -0.69 | -0.62 | -0.59 | -0.51 | -0.36 | -0.37 | -0.39 | -0.38 | -0.36 | -0.36 | -0.39 | -0.21 | -0.3 | -0.29 | -0.21 | -0.37 | 0.23 |
| EBITDA
| -76.331 | -65.15 | -52.588 | -46.437 | -38.783 | -34.062 | -30.21 | -29.299 | -20.388 | -18.733 | -17.688 | -17.378 | -12.427 | -9.85 | -0.623 | -1.366 | -0.738 | -4.551 | -3.645 |
| EBITDA Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7.146 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |